[Antithrombotic prevention and therapy in coronary heart disease]

Internist (Berl). 1997 Jul;38(7):658-66. doi: 10.1007/s001080050077.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Clinical Trials as Topic
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / prevention & control*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Aggregation / drug effects

Substances

  • Fibrinolytic Agents
  • Aspirin